glp 1 and psoriatic arthritis GLP-1 receptor agonists: emerging therapeutic potential in psoriasis management — current evidence future outlook | European Journal of Clinical Pharmacology GLP-1 Drugs Tackle Both Skin

Studies suggest that both medications can reduce heart-related conditions like stroke or heart attack in patients with type 2 diabetes and heart disease

Tibial area bone mineral density (BMD) was increased, but total and vertebral area BMDs were unchanged

Even the most effective tyrosinase inhibitor cannot compete with daily unprotected sun on the same spot

V.da MataA.et al (2019)

The mean change in weight at 72 weeks was 35.5 lb with the 5 mg dose, 48.9 lb with the 10 mg dose, and 52 lb with the 15 mg dose

Extrahepatic malignancies - particularly colorectal, breast, and pancreatic cancer - are more common in MASLD patients independent of metabolic syndrome components [3-5]